OrthoBuzz occasionally receives posts from guest bloggers. This guest post comes from Chad Krueger, MD, in response to an article at MedCityNews.com that announced a 3-D printing alliance between Johnson & Johnson and HP.
There’s much focus lately on healthcare concepts in which each patient’s treatment is tailored to his or her specific condition, anatomy, and, in some cases, genetic make-up. Within that realm of so-called “personalized medicine,” surgeons are becoming increasingly interested in tailoring procedures and implants to specific individuals. The MedCity News article discusses how Johnson & Johnson has partnered with HP to further develop 3-D printing capabilities, with a goal of giving surgeons more patient-specific options.
The article also discusses how customized 3-D-printed implants have already been used at some facilities for “unique” patients, such as those whose challenging revision surgery would normally require substantial “trial and error” intraoperatively to properly fit implants. This printing technology can also facilitate production of customized cutting jigs, retractors, and other tools specific to individual patients. Companies are even using 3-D technology to develop casts, braces, and other interventions used in the nonoperative treatment of orthopaedic conditions (see related OrthoBuzz post).
Additionally, 3-D printing can be used in the preoperative period to provide surgeons with a better understanding of the bony anatomy they will encounter during a case. This type of preoperative templating is already being used on complex heterotopic ossification removals, spinal deformity corrections, and other difficult operations. These 3-D-printed models can also be used to educate patients and increase their understanding of the planned procedure.
Despite all the promise surrounding 3-D printing, hurdles are abundant. For example, an entirely new regulatory framework will need to be developed to ensure the quality and safety of these products. Even if the capabilities of this technology increase and the costs decrease, we must remember the many other exciting device technologies that elicited similar early excitement but were found to be less useful than anticipated.
Nevertheless, companies such as Stryker are already spending hundreds of millions of dollars to build facilities devoted to industrial 3-D printing, and they will be looking for a return on that investment. So, despite the exhilaration and promise that come with new technologies, it is important to recognize their potential limitations—and to have open discussions with patients about all that remains unknown in regard to their use.
Chad Krueger, MD is a military orthopaedic surgeon at Womack Army Medical Center in Fort Bragg, NC.
Click here to read a JBJS Reviews article about the surgeon’s role in introducing new orthopaedic technologies.